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Abstract: Cytokeratin expression has been documented in a variety of sarcomas including synovial sarcomas, epithelioid 
sarcomas, Ewing’s sarcomas and, rarely, osteosarcomas. In osteosarcomas immunohistochemically shown to expression 
cytokeratins, a component of epithelioid cells is generally present. These epithelioid cytokeratin positive cells raise the 
possibility of metastatic disease with prognostic and therapeutic implications differing from primary osteosarcoma. The 
cytokeratin-expressing cells of the cases reported in the literature have not shown deﬁ  nitive squamous differentiation with 
keratin pearl formation. We report a case of osteosarcoma in which islands of malignant squamous cells were present show-
ing keratin pearl formation and expression of cytokeratins.
Keywords: osteosarcoma, cytokeratin, squamous differentiation
Introduction
Cytokeratin expression has been documented by immunohistochemistry in a variety of sarcomas
1 
including synovial sarcoma.
2–9 Only synovial sarcomas and epithelioid sarcomas are believed to show 
true epithelial differentiation, while the other sarcomas express so-called “anomalous” cytokeratins.
1 
Cytokeratins have been rigorously classiﬁ  ed by Moll et al.
10 In sarcomas with “anomalous” cyto-
keratin expression, the cytokeratin is expressed by a minority of cells and is present in only a portion 
of the cytoplasm.
1 Most of the sarcomas with “anomalous” cytokeratin expression only express cyto-
keratins 8 and 18 as detected by CAM 5.2. Cytokeratin expression has been documented in osteoblas-
tic, ﬁ  broblastic and chondroblastic osteosarcomas.
2 Cytokeratin is most strongly and extensively 
expressed in osteosarcomas with an extensive epithelioid cell component.
2 Cytokeratin in these cases 
is detected by antibodies AE1,3 and is present only in the epithelioid cells. AE1,3 is an antibody mix-
ture reactive against cytokeratins 56.5, 50, 51, 48, 40, 67, 66, 65, 64, 59, 58, 56 and 52 KD as described 
by Moll et al.
10 These epithelial osteosarcomas contain a component of cells with eccentrically located 
vesicular nuclei, prominent nucleoli and abundant pale eosinophilic cytoplasm.
6 Such osteosarcomas 
require distinction from metastases to bone. This is usually achieved by excluding an epithelial primary 
elsewhere and demonstration of malignant osteoid. The majority of cases reported do not produce 
clearly identiﬁ  able epithelial structures such as glands, ducts or squamous epithelium with dykeratotic 
cells or keratin pearl formation.
2–9 Some osteosarcomas expressing cytokeratins have demonstrated 
rosette-like structures.
6
We report a case of osteosarcoma in which a minority population of cells demonstrated striking dif-
ferentiation towards squamous epithelium with dykeratotic cells and keratin pearls. The cells reacted 
with antibodies against AE1,3. This squamous differentiation made distinction from metastatic disease 
difﬁ  cult. Herein we report the clinical and pathologic ﬁ  ndings in this case.
Case Report
The patient is a 33-year-old woman who reported to the University of Utah Sarcoma Service Clinic for 
evaluation of a mass just above her left knee. The mass was associated with local pain, but she was 
otherwise asymptomatic. Bone scan and physical examination disclosed no other lesions. Radiologic 
examination disclosed a bone lesion most consistent with osteosarcoma (Fig. 1). Following biopsy, an 
en bloc resection of the distal femur was performed.56
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Histopathology
Both the biopsy and resection specimen were 
ﬁ  xed in 10% neutral buffered formalin. Five 
micron H&E-stained sections were prepared, 
and immunohistochemistry for cytokeratins 
AE1,3, CAM 5.2, vimentin, S-100 protein, CK 
5/6, CK 7, CK 19, CK 20 and HER-2/neu was 
performed. The antibody AE1,3 was supplied by 
Boehringer Mannheim (Mannheim, Germany) 
and used at a dilution of 1:2800. CAM 5.2 was 
supplied by Novocastra (Newcastle on Tyne, 
UK) and used at a dilution of 1:40. Vimentin 
used at a dilution of 1:30, S-100 used at a dilu-
tion of 1:300 and prediluted Her-2/neu were all 
supplied by Dako (Glostrap, Denmark). CK 5/6 
was supplied by Chemicon (Temecula, Califor-
nia) and used at a dilution of 1:400. CK 7 used 
at a dilution of 1:800 and CK 20 used at a dilu-
tion of 1:200 were supplied by Dako (Glostrap, 
Denmark). CK19 was supplied by Vision Bio-
systems (Norwell, Massachusetts) and was used 
at a dilution of 1:400.
Sections of the biopsy and resection specimen 
revealed an osteocartilaginous neoplasm in which 
were scattered small islands of epithelioid cells 
focally showing keratin pearl formation (Fig. 2A). 
These cells had enlarged hyperchromatic nuclei 
with a vesicular chromatin pattern and prominent 
nucleoli. The cytoplasm was eosinophilic. Inter-
cellular bridges were visible (Fig. 2B). Immuno-
histochemistry for cytokeratins AE1,3, CK 7, CK 
5/6 and CAM 5.2 revealed the nests of epithelioid 
cells to stain strongly for cytokeratins (Fig. 3). 
Immunohistochemical stains for vimentin, CK 
19, CK 20, S-100 protein and HER-2/neu did not 
react with these cells. The majority of the neo-
plasm was composed of cartilaginous islands, 
woven bone and areas of direct tumor osteoid 
formation. A diagnosis of chondroblastic osteo-
sarcoma was made.
Discussion
Sarcomas showing epithelial differentiation with 
immunohistochemical demonstration of cyto-
keratin are well recognized and include synovial 
sarcoma and epithelioid sarcoma.
1 Less com-
monly, other sarcomas may demonstrate minor 
populations of cytokeratin positive cells.
1 Only 
synovial sarcomas and epithelioid sarcomas are 
believed to show true epithelial differentiation as 
characterized by the production of high molecular 
weight cytokeratins
1, 10 and the production of 
clearly recognizable glandular or squamous ele-
ments.
1 The epithelial differentiation and cyto-
keratin production seen in the other sarcoma types 
has been termed “anomalous”.
1 This “anomalous” 
cytokeratin staining is characterized by a limited 
distribution in a subset of neoplastic cells and is 
conﬁ  ned to only a portion of the cytoplasm of 
those cells. Most sarcomas with “anomalous” 
cytokeratin production express cytokeratins lim-
ited to Moll’s catalogue 8 and 18 keratins corre-
sponding to positive staining with CAM 5.2.
1 Rare 
examples of osteosarcoma have been reported 
which show epithelial differentiation.
2–9 Some 
reported cases have shown glandular or rosette-
like features.
6 The majority of cases have demon-
strated immunohistochemical reactivity for 
epithelial membrane antigen and CAM 5.2.
6, 9, 11 
More rarely, osteosarcomas containing cells 
decorating with the antibody to cytokeratins AE1,3 
have been reported.
8 Most commonly, epithelial 
differentiation takes the form of small nests and 
clusters of polygonal epithelioid cells which lack 
deﬁ  nitive glandular or squamous differentiation. 
These osteosarcomas are referred to as epithelioid 
osteosarcomas
12 and require distinction from 
metastatic disease.
Figure 1. Radiograph showing an osteolytic and osteoblastic intra-
medullary tumor characteristic of osteosarcoma.57
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Osteosarcomas with epithelial differentiation are 
relatively rare, and rarer still are those showing 
rosette-like, glandular or squamous differentiation. 
A small number of osteosarcomas have been reported 
with glandular or rosette-like differentiation and/or 
high molecular weight cytokeratin expression.
6, 8, 9 
Some of these osteosarcomas including our case have 
a chondroblastic morphology.
9 Our case demon-
strated clear-cut squamous differentiation including 
keratin pearl formation. This adds to the spectrum 
Figure 2. A) Keratin pearl composed of well differentiated neoplastic  squamous cells within a zone of chondroid (H&E, ×40). B) Nest of 
malignant squamous cells showing intercellular bridges (H&E, ×100).58
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of epithelial differentiation reported in the literature 
and expands the potential differential diagnosis to 
include metastatic squamous cell carcinoma.
Primary bone neoplasms containing a low grade 
osteocartilagenous component and a cellular com-
ponent showing epithelial differentiation raise the 
differential diagnosis of metastatic carcinoma with 
reactive bone formation, osteosarcoma with focal 
epithelial differentiation, and true carcinosarcoma. 
Carcinomatous metastases to bone are most com-
monly associated with a clinically or radiographi-
cally demonstrable primary lesion elsewhere in the 
body. The reactive bone associated with epithelial 
metastases usually shows less nuclear atypia than 
is characteristic of osteosarcomas showing focal 
epithelial differentiation. Many epithelial metas-
tases present as osteolytic rather than osteoblastic 
lesions although metastases from some sites are 
characterized by osteoblastic metastases. Primary 
sites which may produce this radiographic picture 
include prostate, breast, stomach, colon, pancreas 
and lung, speciﬁ  cally pulmonary oat cell carci-
noma.
13 Careful clinical, radiographic and patho-
logic correlation is required to recognize the 
metastatic nature of the process. It should also be 
remembered that metastases are far more frequent 
than primary sarcomas in adults.
The presence of both mesenchymal and epithelial 
differentiation within a single neoplasm raises 
theoretical issues as to the origin of the bimorphic 
differentiation. When the epithelial portion of bimor-
phic differentiation is restricted to aberrant cyto-
keratin expression without cytoarchitectural signs 
of epithelial differentiation, two explanations have 
been profferred.
14–15 Swanson suggested that the 
majority of aberrant cytokeratin expression within 
soft tissue sarcomas is due to technical artifacts 
resulting in false positive staining.
14 This is an attrac-
tive proposal attributing the majority of aberrant 
cytokeratin expression in soft tissue sarcomas to 
excessive antigen retrieval, cross reactivity of anti-
bodies or artifacts of ﬁ  xation. However, the immu-
nohistochemical ﬁ  nding of aberrant cytokeratin 
expression have been conﬁ  rmed by other methods 
and cell biological evidence suggesting that cyto-
keratins are expressed in certain mesenchymal cells 
usually considered keratin negative.
11 Cultured fetal 
ﬁ  broblasts have been induced to produce cytokera-
tins as shown by immunohistochemistry and west-
ern blotting techniques. Knapp and Franke
16 have 
suggested that genes for cytokeratins 8 and 18 can 
escape expression regulation in certain circum-
stances and may be aberrantly expressed in some 
soft tissue sarcomas. The immunohistochemical 
Figure 3. Immunohistochemical stain for cytokeratins AE1,3 demonstrating nests of positively staining cells.59
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ﬁ  ndings of cytokeratins of the Moll’s classiﬁ  cation 
8 and 18 need not be a technical artifact but may 
represent true biological expression.
The osteosarcoma reported here and others 
described in the literature
6–8 demonstrate epithelial 
differentiation extending beyond the expression of 
cytokeratins including ultrastructural evidence of 
desmosomes and monoﬁ  laments and glandular or 
rosette-like differentiation. Kramer et al.
8 have 
reviewed several hypotheses formulated to explain 
the pathogenesis of these biphenotypic malignan-
cies. Such tumors may arise from “cell rests” 
displaced from other tissues within the body, as 
collision tumors wherein a separate carcinoma and 
sarcoma amalgamate into an apparently single 
neoplasm or that carcinosarcomas represent exten-
sive metaplasia of neoplasms fundamentally of 
epithelial origin.
8 The most attractive hypothesis 
to explain biphenotypic tumors is that they arise 
from uncommitted multipotential stem cells. In 
this hypothesis, primitive mesenchymal cells dif-
ferentiate in a nonrandom fashion resulting in a 
speciﬁ  c biphenotypic tumor.
8 This hypothesis sug-
gests that primitive mesenchymal cells can acquire 
epithelial morphology and express a variety of 
epithelial products including cytokeratins. Sarco-
mas with signiﬁ  cant heterogeneity would appear 
most likely candidates for the focal production of 
the epithelial phenotype. The known heterogeneity 
of osteogenetic sarcomas would make them likely 
candidates for polyphenotypic differentiation.
2,6
Our case illustrates the ability of osteosarcomas 
to show epithelial differentiation characterized both 
by cytokeratin expression and differentiation to 
squamous cells displaying keratinization and kera-
tin pearl formation. Importantly, our case demon-
strated higher molecular weight cytokeratin 
production (AE1, 3) than usually reported and squa-
mous differentiation in place of a glandular pheno-
type. The present case raises the clinically important 
differential diagnosis between metastatic squamous 
cell carcinoma and osteosarcoma showing focal 
epithelial differentiation. Radiographic, clinical and 
morphologic features aided in the appropriate diag-
nosis of osteosarcoma in this case.
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